PAPER Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS
SEARCH RESULTS
331009 RESULTS
PAPER Ko CY, Chang LH, Lee YC, Sterneck E, Cheng CP, Chen SH, Huang AM, Tseng JT, Wang JM
CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.
Neurobiol Aging. 2012 Feb;33(2):422.e11-25. PubMed: 21112127PAPER Nithianantharajah J, Hannan AJ
Mechanisms mediating brain and cognitive reserve: experience-dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):331-9. PubMed: 21112312PAPER Kurata T, Miyazaki K, Kozuki M, Panin VL, Morimoto N, Ohta Y, Nagai M, Ikeda Y, Matsuura T, Abe K
Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
Brain Res. 2011 Jan 31;1371:161-70. PubMed: 21112317PAPER Humpel C
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Exp Gerontol. 2011 Apr;46(4):225-32. PubMed: 21112383PAPER Barr TL, Alexander S, Conley Y
Gene expression profiling for discovery of novel targets in human traumatic brain injury.
Biol Res Nurs. 2011 Apr;13(2):140-53. PubMed: 21112922PAPER Jang YH, Min do
Nuclear localization of phospholipase D1 mediates the activation of nuclear protein kinase C(alpha) and extracellular signal-regulated kinase signaling pathways.
J Biol Chem. 2011 Feb 11;286(6):4680-9. PubMed: 21113078PAPER Kutzing MK, Langhammer CG, Luo V, Lakdawala H, Firestein BL
Automated Sholl analysis of digitized neuronal morphology at multiple scales.
J Vis Exp. 2010;(45) PubMed: 21113115PAPER Li X, Coyle D, Maguire L, Watson DR, McGinnity TM
Gray matter concentration and effective connectivity changes in Alzheimer's disease: a longitudinal structural MRI study.
Neuroradiology. 2011 Oct;53(10):733-48. PubMed: 21113707PAPER Camozzato AL, Kochhann R, Godinho C, Costa A, Chaves ML
Validation of a telephone screening test for Alzheimer's disease.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011 Mar;18(2):180-94. PubMed: 21113824PAPER Stravalaci M, Beeg M, Salmona M, Gobbi M
Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Aβ(1-42) peptide, synthesized by depsi-peptide technique.
Biosens Bioelectron. 2011 Jan 15;26(5):2772-5. PubMed: 21112205PAPER Weiss R, Lifshitz V, Frenkel D
TGF-β1 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis.
Brain Behav Immun. 2011 Jul;25(5):1017-24. PubMed: 21112386PAPER Cissé M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, Orr A, Lotz G, Kim DH, Hamto P, Ho K, Yu GQ, Mucke L
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
Nature. 2011 Jan 6;469(7328):47-52. PubMed: 21113149PAPER Kapai NA, Solntseva EI, Skrebitskii VG
Donepezil eliminates suppressive effects of β-amyloid peptide (1-42) on long-term potentiation in the hippocampus.
Bull Exp Biol Med. 2010 Jul;149(1):33-6. PubMed: 21113452PAPER Ott S, Henkel AW, Henkel MK, Redzic ZB, Kornhuber J, Wiltfang J
Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.
Mol Cell Biochem. 2011 Mar;349(1-2):169-77. PubMed: 21113648Current Filters
No filters selected